Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8373
|
pubmed:dateCreated |
1984-3-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
406-7
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6198570-Adult,
pubmed-meshheading:6198570-Aged,
pubmed-meshheading:6198570-Female,
pubmed-meshheading:6198570-Humans,
pubmed-meshheading:6198570-Immunization, Passive,
pubmed-meshheading:6198570-Infusions, Parenteral,
pubmed-meshheading:6198570-Male,
pubmed-meshheading:6198570-Middle Aged,
pubmed-meshheading:6198570-Myasthenia Gravis,
pubmed-meshheading:6198570-gamma-Globulins
|
pubmed:year |
1984
|
pubmed:articleTitle |
High-dose intravenous gammaglobulin for myasthenia gravis.
|
pubmed:publicationType |
Letter
|